Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed question first answered answering member label
tabling member	label

Search

755157

registered interest
date	20/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government, further to the Written Answer by Lord O'Shaughnessy on 19 July (HL914), what plans they have to reduce the costs to the NHS of the supply of drugs such as Apomorphine that are long out of patent and simple and cheap to manufacture; and what consideration they have given to increasing supplies of such drugs by seeking suppliers who will invest in regulatory approvals in exchange for a fixed-price, fixed-term contract.
tabling member printed	Lord Lucas
uin	HL1165
answer	answer is ministerial correction date of answer 31/07/2017 answer text <p>The cost of branded medicines to the National Health Service is controlled by the voluntary pharmaceutical price regulation scheme or the statutory medicines price regulation scheme. Often when patents expire, generic versions enter the market and, as a result of competition, prices often go down.</p><p> </p><p>In primary care, the community pharmacy contractual framework provides an incentive for pharmacies to get the best medicines prices; in secondary care, a system of central tenders delivers similar levels of savings. In general, the system works well – the United Kingdom has the lowest generic prices across the Organisation for Economic Co-operation and Development.</p> answering member printed Lord O'Shaughnessy question first answered 31/07/2017 14:28:31 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	1879 label Biography information for Lord Lucas

752468

registered interest
date	17/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Parkinson's Disease: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government how much the NHS pays for a one year supply of Apomorphine for a patient with Parkinson's Disease; how much they estimate it costs to manufacture a year's supply of that drug; what assessment they have made of the difficulties of manufacturing Apomorphine to clinical standards; and whether they intend to take any steps to reduce the cost of that drug to the NHS.
tabling member printed	Lord Lucas
uin	HL914
answer	answer is ministerial correction date of answer 19/07/2017 answer text <p>The drug cost to the National Health Service for a one year supply of Apomorphine for a patient with Parkinson's Disease is estimated to be in the region of £5,300 and £9,000, based on the usual daily dose of 3 – 30mg. However, the maximum daily is 100mg, so the annual cost for some patient’s treatment may be higher.</p><p>We have no estimate of the cost of manufacture. We are not aware of any particular issues relating to the manufacture of this drug. Pharmaceutical companies participate in either the voluntary pharmaceutical price regulation scheme (PPRS) or the statutory medicines price regulation scheme, both of which regulate the cost of medicines to the NHS. Products covered by the statutory scheme are subject to a 15% cut to their list price. Companies in the PPRS pay a percentage of sales to the Government when growth in NHS spending on medicines exceeds an agreed level. NHS purchasers may also negotiate discounts with pharmaceutical companies in addition to national price regulation.</p><p> </p> answering member printed Lord O'Shaughnessy question first answered 19/07/2017 15:12:09 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	1879 label Biography information for Lord Lucas